ReviewJournal of personalized medicine2025

Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection.

Amer E Alkhalifa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.